Literature DB >> 26360253

High-throughput sequencing reveals an altered T cell repertoire in X-linked agammaglobulinemia.

Manish Ramesh1, Noa Simchoni2, David Hamm3, Charlotte Cunningham-Rundles4.   

Abstract

To examine the T cell receptor structure in the absence of B cells, the TCR β CDR3 was sequenced from DNA of 15 X-linked agammaglobulinemia (XLA) subjects and 18 male controls, using the Illumina HiSeq platform and the ImmunoSEQ analyzer. V gene usage and the V-J combinations, derived from both productive and non-productive sequences, were significantly different between XLA samples and controls. Although the CDR3 length was similar for XLA and control samples, the CDR3 region of the XLA T cell receptor contained significantly fewer deletions and insertions in V, D, and J gene segments, differences intrinsic to the V(D)J recombination process and not due to peripheral T cell selection. XLA CDR3s demonstrated fewer charged amino acid residues, more sharing of CDR3 sequences, and almost completely lacked a population of highly modified Vβ gene segments found in control DNA, suggesting both a skewed and contracted T cell repertoire in XLA.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amino acid sequence; High throughput sequencing; Junctional diversity; T cell receptor; XLA

Mesh:

Substances:

Year:  2015        PMID: 26360253      PMCID: PMC4658265          DOI: 10.1016/j.clim.2015.09.002

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  33 in total

1.  B cell-dependent TCR diversification.

Authors:  Cristina João; Brenda M Ogle; Carlota Gay-Rabinstein; Jeffrey L Platt; Marilia Cascalho
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

2.  The health status and quality of life of adults with X-linked agammaglobulinemia.

Authors:  Vanessa Howard; Jeffrey M Greene; Savita Pahwa; Jerry A Winkelstein; John M Boyle; Mehmet Kocak; Mary Ellen Conley
Journal:  Clin Immunol       Date:  2005-12-22       Impact factor: 3.969

Review 3.  Bruton's tyrosine kinase--an integral protein of B cell development that also has an essential role in the innate immune system.

Authors:  Gabriela López-Herrera; Alexander Vargas-Hernández; Maria Edith González-Serrano; Laura Berrón-Ruiz; Juan Carlos Rodríguez-Alba; Francisco Espinosa-Rosales; Leopoldo Santos-Argumedo
Journal:  J Leukoc Biol       Date:  2013-11-18       Impact factor: 4.962

4.  Human syndromes of immunodeficiency and dysregulation are characterized by distinct defects in T-cell receptor repertoire development.

Authors:  Xiaomin Yu; Jorge R Almeida; Sam Darko; Mirjam van der Burg; Suk See DeRavin; Harry Malech; Andrew Gennery; Ivan Chinn; Mary Louise Markert; Daniel C Douek; Joshua D Milner
Journal:  J Allergy Clin Immunol       Date:  2014-01-07       Impact factor: 10.793

5.  T cell activity and cytokine production in X-linked agammaglobulinemia: implications for vaccination strategies.

Authors:  A Plebani; M B Fischer; A Meini; M Duse; V Thon; M M Eibl
Journal:  Int Arch Allergy Immunol       Date:  1997-09       Impact factor: 2.749

6.  Overlap and effective size of the human CD8+ T cell receptor repertoire.

Authors:  Harlan S Robins; Santosh K Srivastava; Paulo V Campregher; Cameron J Turtle; Jessica Andriesen; Stanley R Riddell; Christopher S Carlson; Edus H Warren
Journal:  Sci Transl Med       Date:  2010-09-01       Impact factor: 17.956

Review 7.  Effector and regulatory B cells: modulators of CD4+ T cell immunity.

Authors:  Frances E Lund; Troy D Randall
Journal:  Nat Rev Immunol       Date:  2010-03-12       Impact factor: 53.106

8.  T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections.

Authors:  E A L Bateman; L Ayers; R Sadler; M Lucas; C Roberts; A Woods; K Packwood; J Burden; D Harrison; N Kaenzig; M Lee; H M Chapel; B L Ferry
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

Review 9.  Successful approach to treatment of Helicobacter bilis infection in X-linked agammaglobulinemia.

Authors:  Stuart E Turvey; Sara H Leo; Annette Boos; Gregory D Deans; Julie Prendiville; Richard I Crawford; Christof Senger; Mary Ellen Conley; Peter Tilley; Anne Junker; Loretta Janz; Robert Azana; Linda Hoang; Tracy L Morton
Journal:  J Clin Immunol       Date:  2012-07-28       Impact factor: 8.317

10.  Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells.

Authors:  C I Smith; B Baskin; P Humire-Greiff; J N Zhou; P G Olsson; H S Maniar; P Kjellén; J D Lambris; B Christensson; L Hammarström
Journal:  J Immunol       Date:  1994-01-15       Impact factor: 5.422

View more
  4 in total

1.  Primary/Congenital Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 5.

Authors:  Dita Gratzinger; Elaine S Jaffe; Amy Chadburn; John K C Chan; Daphne de Jong; John R Goodlad; Jonathan Said; Yasodha Natkunam
Journal:  Am J Clin Pathol       Date:  2017-02-01       Impact factor: 2.493

2.  A new high-throughput sequencing method for determining diversity and similarity of T cell receptor (TCR) α and β repertoires and identifying potential new invariant TCR α chains.

Authors:  Kazutaka Kitaura; Tadasu Shini; Takaji Matsutani; Ryuji Suzuki
Journal:  BMC Immunol       Date:  2016-10-11       Impact factor: 3.615

3.  Naïve Regulatory T Cell Subset Is Altered in X-Linked Agammaglobulinemia.

Authors:  Pavel V Shelyakin; Ksenia R Lupyr; Evgeny S Egorov; Ilya A Kofiadi; Dmitriy B Staroverov; Sofya A Kasatskaya; Valeriia V Kriukova; Irina A Shagina; Ekaterina M Merzlyak; Tatiana O Nakonechnaya; Elena A Latysheva; Irina A Manto; Musa R Khaitov; Sergey A Lukyanov; Dmitriy M Chudakov; Olga V Britanova
Journal:  Front Immunol       Date:  2021-08-19       Impact factor: 7.561

Review 4.  T Cell Abnormalities in X-Linked Agammaglobulinaemia: an Updated Review.

Authors:  Sanchi Chawla; Ankur Kumar Jindal; Kanika Arora; Rahul Tyagi; Manpreet Dhaliwal; Amit Rawat
Journal:  Clin Rev Allergy Immunol       Date:  2022-06-16       Impact factor: 10.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.